Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/?Refractory CD19+ B-cell Malignancies
Complete Title: UB-VV111-01 A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF UB-VV111 IN COMBINATION WITH RAPAMYCIN IN RELAPSED OR REFRACTORY (R/R) CD19+ B-CELL MALIGNANCIES
Trial Phase: I
Investigator: Ajay Gopal
This study is a Phase 1 dose-escalation and dose-confirmation study to evaluate the safety and antitumor activity of UB-VV111. The study will enroll patients with relapsed/refractory large B-cell lymphoma (LBCL) and chronic lymphocytic leukemia (CLL).
Keywords:
- Leukemia, Chronic Lymphocytic (CLL); Lymphoma, Non-Hodgkin (NHL); Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.